Assessment of cardiac events via 24-hour electrocardiographic (Holter) monitoring with cilomilast in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 66s Year: 2003
Prevalence of echocardiographic disturbances in SAHS patients. Relationship to disease severity Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
Myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring Source: International Congress 2015 – COPD: interesting notes Year: 2015
24-hour arterial stiffness monitoring values in patients with COPD Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
Evaluation of electrocardiographic (ECG) changes in subjects with severe asthma or COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005
Electrocardiographic and echocardiographic abnormalities in COPD patients according to disease severity Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011
Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018
The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Effect of comorbidities on severity and clinical parameters of COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 66s Year: 2004
Relationship between heart rate variability and disease characteristics in patients with COPD Source: Annual Congress 2008 - Rehabilitation and influencing factors Year: 2008
Correlation between heart rate variability indexes and aerobic physiological variables in patients with COPD Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma Year: 2013
BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
24-hour blood pressure monitoring and 10 years systemic coronary risk evaluation in patients with bronchial asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013
Decreased fractal dimension of heart rate dynamics in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006
Is there any relationship between the duration to diagnosis of COPD and severity of the disease? Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012
Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007
The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire Source: International Congress 2014 – COPD markers Year: 2014